Table 3 Relative risks for increases in visits to GP surgeries, A&E departments, and admission to hospital for asthma associated with increases in fungal spore concentrations.
| Outcome | Total spores | Deuteromycota | Basidiomycota | Ascomycota | |||||
|---|---|---|---|---|---|---|---|---|---|
| RR | 95% CI | RR | 95% CI | RR | 95% CI | RR | 95% CI | ||
| Children | |||||||||
| GP visits | Q1 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Q2 | 1.05 | (0.95 to 1.17) | 1.00 | (0.90 to 1.10) | 0.93 | (0.83 to 1.04) | 0.97 | (0.87 to 1.09) | |
| Q3 | 1.08 | (0.96 to 1.21) | 0.97 | (0.87 to 1.09) | 1.09 | (0.97 to 1.22) | 1.08 | (0.97 to 1.21) | |
| Q4 | 0.98 | (0.86 to 1.11) | 0.97 | (0.86 to 1.10) | 1.01 | (0.90 to 1.14) | 0.93 | (0.83 to 1.05) | |
| AE visits | Q1 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Q2 | 1.04 | (0.94 to 1.15) | 1.00 | (0.91 to 1.11) | 0.99 | (0.89 to 1.11) | 1.02 | (0.91 to 1.14) | |
| Q3 | 1.06 | (0.95 to 1.17) | 1.03 | (0.93 to 1.15) | 1.14 | (1.02 to 1.27) | 1.01 | (0.90 to 1.14) | |
| Q4 | 1.06 | (0.94 to 1.18) | 1.00 | (0.89 to 1.13) | 1.07 | (0.96 to 1.20) | 1.15 | (1.02 to 1.29) | |
| Admissions | Q1 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Q2 | 1.01 | (0.92 to 1.10) | 1.04 | (0.95 to 1.14) | 1.07 | (0.97 to 1.18) | 0.98 | (0.89 to 1.09) | |
| Q3 | 1.04 | (0.95 to 1.15) | 1.05 | (0.96 to 1.15) | 1.16 | (1.04 to 1.28) | 1.06 | (0.95 to 1.18) | |
| Q4 | 1.07 | (0.97 to 1.19) | 1.05 | (0.94 to 1.18) | 1.10 | (0.99 to 1.23) | 1.07 | (0.96 to 1.20) | |
| Adults | |||||||||
| GP visits | Q1 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Q2 | 1.02 | (0.94 to 1.11) | 1.01 | (0.93 to 1.10) | 1.06 | (0.97 to 1.16) | 1.02 | (0.93 to 1.11) | |
| Q3 | 1.03 | (0.94 to 1.12) | 0.98 | (0.90 to 1.08) | 1.12 | (1.03 to 1.23) | 1.03 | (0.95 to 1.13) | |
| Q4 | 1.01 | (0.92 to 1.11) | 1.07 | (0.98 to 1.18) | 1.07 | (0.97 to 1.17) | 0.98 | (0.89 to 1.08) | |
| AE visits | Q1 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Q2 | 0.95 | (0.86 to 1.05) | 0.94 | (0.85 to 1.04) | 1.06 | (0.96 to 1.17) | 1.08 | (0.97 to 1.20) | |
| Q3 | 0.96 | (0.87 to 1.07) | 1.03 | (0.93 to 1.15) | 1.02 | (0.91 to 1.13) | 1.02 | (0.91 to 1.15) | |
| Q4 | 0.96 | (0.86 to 1.08) | 1.03 | (0.92 to 1.16) | 0.99 | (0.89 to 1.11) | 1.03 | (0.91 to 1.15) | |
| Admissions | Q1 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Q2 | 1.00 | (0.91 to 1.11) | 0.98 | (0.88 to 1.08) | 1.03 | (0.93 to 1.14) | 1.12 | (1.00 to 1.25) | |
| Q3 | 1.04 | (0.93 to 1.15) | 1.06 | (0.95 to 1.18) | 1.01 | (0.91 to 1.13) | 1.07 | (0.95 to 1.20) | |
| Q4 | 0.99 | (0.88 to 1.11) | 1.01 | (0.90 to 1.14) | 1.02 | (0.91 to 1.15) | 1.01 | (0.89 to 1.14) | |
Q1–4, quartiles of fungal spore concentrations; Q1, baseline.